Armistice Capital’s Biogen BIIB Stock Holding History

Armistice Capital’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-100,049	Closed	-$21.6M	–	273
2024 Q1	$21.6M	Sell	100,049 -99,951	-50%	-$23.4M	0.29%	65
2023 Q4	$51.8M	Sell	200,000 -76,788	-28%	-$18.9M	0.71%	26
2023 Q3	$71.1M	Buy	276,788 +20,788	+8%	+$5.56M	1.09%	8
2023 Q2	$72.9M	Sell	256,000 -194,000	-43%	-$57.7M	1.06%	15
2023 Q1	$125M	Buy	450,000 +50,000	+13%	+$13.8M	1.8%	9
2022 Q4	$111M	Buy	400,000 +176,000	+79%	+$49.7M	1.93%	9
2022 Q3	$59.8M	Sell	224,000 -12,000	-5%	-$2.55M	1.04%	23
2022 Q2	$48.1K	Sell	236,000 -336,000	-59%	-$68.7M	0.84%	29
2022 Q1	$120M	Buy	572,000 +112,000	+24%	+$24.4M	2.33%	5
2021 Q4	$110M	Buy	460,000 +88,000	+24%	+$22.6M	1.81%	9
2021 Q3	$105M	Buy	372,000 +4,000	+1%	+$1.31M	1.78%	8
2021 Q2	$127M	Buy	368,000 +80,000	+28%	+$24.2M	2.28%	4
2021 Q1	$80.6M	Buy	288,000 +30,000	+12%	+$8.09M	1.85%	11
2020 Q4	$63.2M	Buy	258,000 +158,000	+158%	+$40.8M	2.15%	9
2020 Q3	$28.4M	Sell	100,000 -116,000	-54%	-$32.4M	1.03%	38
2020 Q2	$57.8M	Buy	216,000 +158,000	+272%	+$47.5M	2.53%	6
2020 Q1	$18.4M	Sell	58,000 -70,000	-55%	-$21.2M	1.13%	36
2019 Q4	$38M	Sell	128,000 -20,000	-14%	-$5.55M	2.19%	8
2019 Q3	$34.5M	Buy	148,000 +120,000	+429%	+$27.9M	2.28%	14
2019 Q2	$6.55M	Sell	28,000 -122,000	-81%	-$28.2M	0.41%	46
2019 Q1	$35.5M	Buy	+150,000	New	+$47.2M	1.94%	15

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Armistice Capital's BIIB Position: Q2 2024 in Review

Armistice Capital sold out of Biogen (BIIB) in Q2 2024, closing a stake of 100,049 shares — an estimated $21.6M sold.

Armistice Capital first reported a position in BIIB in Q1 2019 and held it in 21 quarters. The position peaked at $127M in Q2 2021. 943 funds tracked by Wall St. Rank hold BIIB as of Q2 2024.

Armistice Capital reported no remaining Biogen position as of Q2 2024 after selling out during the quarter.
Armistice Capital sold 100,049 Biogen shares in Q2 2024, an estimated $21.6M.
Armistice Capital first reported a position in Biogen in Q1 2019 and held it in 21 quarters.
Armistice Capital's Biogen position peaked at $127M in Q2 2021.
943 funds tracked by Wall St. Rank held Biogen as of Q2 2024.

Based on Armistice Capital's 13F filing for Q2 2024, filed 14 Aug 2024.